A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Clinical trial NCT06339008 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06339008
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-26
- Primary completion
- 2026-09-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.